Actinium Pharmaceuticals, Inc. (ATNM) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US00507W2061
Actinium Pharmaceuticals, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 90,000.00 USD |
| Operating income | -36.25 m USD |
| EBIT | -36.25 m USD |
| Net income | -33.89 m USD |
| Diluted EPS – continuing operations | -1.09 USD |
Full history since 2006, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a antibody radioconjugate that deliver alpha-emitter Ac-225 to prostate cancer cells. In addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia. Further, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies, and its research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company is based in New York, New York.
More stocks
- Dongbang Agro (007590.KS)
- Mofast AB (MOFAST.ST)
- BASO Precision Optics Co., LTD (6517.TWO)
- Linz Textil Holding AG (LTH.VI)
- Kodiak Copper Corp (KDK.V)
- Zimmite Taiwan Ltd (8435.TWO)
- Arlitech Electronic (6432.TWO)
- Elton International Trading Company S.A (ELTON.AT)
- Forward Electronics Co., Ltd. (8085.TWO)
- Budi Starch & Sweetener Tbk (BUDI.JK)
- Single Well Industrial (3490.TWO)
- TROPHY GAMES Development AS (TGAMES.CO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.